InfuSystems Holdings (FRA:1TZ) Cyclically Adjusted PS Ratio: (As of Aug. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:1TZ InfuSystems Holdings Inc FRA:1TZ
85 GF Score
Price €8.10
GF Value €8.05
! 2 Warning Signs
View Full Analysis

What is InfuSystems Holdings Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


InfuSystems Holdings  (FRA:1TZ) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


InfuSystems Holdings Cyclically Adjusted PS Ratio Related Terms


InfuSystems Holdings Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for InfuSystems Holdings's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InfuSystems Holdings Cyclically Adjusted PS Ratio Chart

InfuSystems Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.43 2.04 2.29 1.70 1.67

InfuSystems Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.20 1.95 1.67 1.67 0.00

FRA:1TZ vs LUCD, QTRX, QSI: Cyclically Adjusted PS Ratio Comparison

For the Medical Devices subindustry, InfuSystems Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InfuSystems Holdings Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where InfuSystems Holdings's Cyclically Adjusted PS Ratio falls into.


FRA:1TZ
85GF Score
InfuSystems Holdings Inc FRA:1TZ
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InfuSystems Holdings Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

InfuSystems Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, InfuSystems Holdings's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.532/333.9520*333.9520
=1.532

Current CPI (Jun. 2026) = 333.9520.

InfuSystems Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.667 241.428 0.923
201612 0.706 241.432 0.977
201703 0.728 243.801 0.997
201706 0.663 244.955 0.904
201709 0.648 246.819 0.877
201712 0.701 246.524 0.950
201803 0.585 249.554 0.783
201806 0.619 251.989 0.820
201809 0.691 252.439 0.914
201812 0.790 251.233 1.050
201903 0.822 254.202 1.080
201906 0.848 256.143 1.106
201909 0.944 256.759 1.228
201912 0.894 256.974 1.162
202003 0.979 258.115 1.267
202006 1.067 257.797 1.382
202009 0.985 260.280 1.264
202012 0.925 260.474 1.186
202103 0.937 264.877 1.181
202106 0.934 271.696 1.148
202109 1.097 274.310 1.336
202112 1.057 278.802 1.266
202203 1.179 287.504 1.369
202206 1.243 296.311 1.401
202209 1.284 296.808 1.445
202212 1.119 296.797 1.259
202303 1.360 301.836 1.505
202306 1.356 305.109 1.484
202309 1.377 307.789 1.494
202312 1.340 306.746 1.459
202403 1.387 312.332 1.483
202406 1.442 314.175 1.533
202409 1.470 315.301 1.557
202412 1.489 315.605 1.576
202503 1.520 319.799 1.587
202506 1.482 322.561 1.534
202509 1.484 324.800 1.526
202512 1.481 324.054 1.526
202603 1.395 330.213 1.411
202606 1.532 333.952 1.532

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is InfuSystems Holdings (FRA:1TZ) Overvalued in 2026?

Based on GuruFocus' analysis, InfuSystems Holdings stock appears to be overvalued. The current stock price of €8.10 is trading 0.6% above its estimated GF Value™ of €8.05.

Key valuation signals for FRA:1TZ:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €8.05 vs. price of €8.10 (0.6% above fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the FRA:1TZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


InfuSystems Holdings Business Description

Other Exchanges INFU:USA
Address 3851 West Hamlin Road, Rochester Hills, MI, USA, 48309
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
85GF Score

Get the complete analysis for FRA:1TZ

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.10
Price
€8.05
GF Value